Cardiovascular health in African Americans: a scientific statement from the American Heart Association

MR Carnethon, J Pu, G Howard, MA Albert… - Circulation, 2017 - ahajournals.org
Background and Purpose: Population-wide reductions in cardiovascular disease incidence
and mortality have not been shared equally by African Americans. The burden of …

Hypertensive retinopathy

TY Wong, P Mitchell - New England Journal of Medicine, 2004 - Mass Medical Soc
This review explains the pathophysiological changes that elevated blood pressure produces
in the retinal circulation. Recent studies show that some specific retinal signs are strong …

Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study

RS Vasan, MG Larson, EP Leip, WB Kannel, D Levy - The Lancet, 2001 - thelancet.com
Summary Background Patients with optimum (> 120/80 mm Hg), normal (120–129/80–84
mm Hg), and high normal (130–139/85–89 mm Hg) blood pressure (BP) may progress to …

Beta‐blockers for hypertension

CS Wiysonge, HA Bradley, J Volmink… - Cochrane database …, 2017 - cochranelibrary.com
Background Beta‐blockers refer to a mixed group of drugs with diverse pharmacodynamic
and pharmacokinetic properties. They have shown long‐term beneficial effects on mortality …

Cardiovascular disease risk factors in HIV patients–association with antiretroviral therapy. Results from the DAD study

N Friis-Møller, R Weber, P Reiss, R Thiébaut, O Kirk… - Aids, 2003 - journals.lww.com
Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD)
among HIV-infected persons, and to investigate any association between such risk factors …

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS …

MJ Brown, CR Palmer, A Castaigne, PW de Leeuw… - The Lancet, 2000 - thelancet.com
Background The efficacy of antihypertensive drugs newer than diuretics and β-blockers has
not been established. We compared the effects of the calcium-channel blocker nifedipine …

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the …

CE Mogensen, S Neldam, I Tikkanen, S Oren… - Bmj, 2000 - bmj.com
Objectives: To assess and compare the effects of candesartan or lisinopril, or both, on blood
pressure and urinary albumin excretion in patients with microalbuminuria, hypertension, and …

Hypertension, hypertensive heart disease and perioperative cardiac risk

SJ Howell, JW Sear, P Foex - British journal of anaesthesia, 2004 - academic.oup.com
The evidence for an association between hypertensive disease, elevated admission arterial
pressure, and perioperative cardiac outcome is reviewed. A systematic review and meta …

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine

V Kothari, RJ Stevens, AI Adler, IM Stratton, SE Manley… - Stroke, 2002 - ahajournals.org
Background and Purpose—People with type 2 diabetes are at elevated risk of stroke
compared with those without diabetes. Relative risks have been examined in earlier work …

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75)

IM Stratton, CA Cull, AI Adler, DR Matthews, HAW Neil… - Diabetologia, 2006 - Springer
Aims/hypothesis The relative importance of glucose and blood pressure control in type 2
diabetes remains uncertain. We assessed interactive effects of glycaemia and systolic blood …